What do VMD's past quarterly earnings reveal about stability?

Viemed Healthcare Inc. (VMD) has demonstrated a stable and growing financial performance over the past quarters, as evidenced by the company's consistent growth in revenue and profitability.

1. **Consistent Growth in Revenue**: VMD has shown a strong upward trend in revenue, with a 23% increase in full-year revenue for 2024 compared to the previous year. This growth was driven by a 20% year-over-year increase in Q4 revenue. The company's ventilator and sleep therapy businesses contributed significantly to this growth, with a 43% increase in sleep business revenue in 2024 compared to 2023.
2. **Stable Profitability**: VMD's adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) has grown by 19% for the full year 2024, reaching a record $51.1 million. The company's gross margin has remained stable at 59.5% for Q4 and 59.4% for the full year 2024, indicating efficient cost management and a strong bottom line.
3. **Positive Cash Flow and Financial Flexibility**: VMD reported a free cash flow of $11.6 million in 2024, representing 5.2% of revenue. The company has a strong balance sheet with $55 million available on credit facilities and no net debt, providing significant financial flexibility.
4. **Future Outlook**: The company's guidance for 2025 projects net revenue growth of 16% and adjusted EBITDA growth of 10%, indicating a positive outlook and confidence in maintaining its growth trajectory.

In conclusion, VMD's past quarterly earnings reveal a stable and growing financial performance, with consistent revenue growth, stable profitability, positive cash flow, and a strong balance sheet. These factors collectively suggest a high degree of financial stability and a positive future outlook for the company.